Product NDC: | 10544-279 |
Proprietary Name: | Nitrofurantoin (monohydrate/macrocrystals) |
Non Proprietary Name: | Nitrofurantoin (monohydrate/macrocrystals) |
Active Ingredient(s): | 25; 75 mg/1; mg/1 & nbsp; Nitrofurantoin (monohydrate/macrocrystals) |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10544-279 |
Labeler Name: | Blenheim Pharmacal, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA080043 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100413 |
Package NDC: | 10544-279-14 |
Package Description: | 14 CAPSULE in 1 BOTTLE (10544-279-14) |
NDC Code | 10544-279-14 |
Proprietary Name | Nitrofurantoin (monohydrate/macrocrystals) |
Package Description | 14 CAPSULE in 1 BOTTLE (10544-279-14) |
Product NDC | 10544-279 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Nitrofurantoin (monohydrate/macrocrystals) |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100413 |
Marketing Category Name | ANDA |
Labeler Name | Blenheim Pharmacal, Inc. |
Substance Name | NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE |
Strength Number | 25; 75 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Nitrofuran Antibacterial [EPC],Nitrofurans [Chemical/Ingredient],Nitrofuran Antibacterial [EPC],Nitrofurans [Chemical/Ingredient] |